Progress and controversies in the treatment of pediatric acute myelogenous leukemia.

Progress and controversies in the treatment of pediatric acute myelogenous leukemia.

Item
http://www.wikidata.org/entity/Q34664671
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.The potential of stem cell therapies for neurological diseases.Understanding the clinical implications of minimal residual disease in childhood leukemia.The rule of four: a systematic approach to diagnosis of common pediatric hematologic and oncologic disorders.Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study.Beginning treatment for pediatric acute myeloid leukemia: the family connection.Hospital charges and length of stay associated with septicemia among children hospitalized for leukemia treatment in the United States.Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China.Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.
P2860

Progress and controversies in the treatment of pediatric acute myelogenous leukemia.

Item
http://www.wikidata.org/entity/Q34664671
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@ast
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@en
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@nl
type
label
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@ast
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@en
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@nl
prefLabel
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@ast
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@en
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Progress and controversies in the treatment of pediatric acute myelogenous leukemia.
@en
P2093
P304
P31
P356
10.1097/00062752-200207000-00014
P433
P478
P577
P698
P921